Back to School: How biopharma can reboot drug development. Access exclusive analysis here

U.S. IPO performance

U.S. IPO performance

U.S. IPO performance
Third quarter IPOs fared well. Only one is below water. Overall, 16 of the 34 U.S. IPOs this window are below water. Mcap in millions
Company Date Price Mcap 9/30 price 9/30mcap Price chg
Acusphere (ACUS)

Read the full 431 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers